<?xml version="1.0" encoding="UTF-8"?>
<ref id="B63-antioxidants-10-00099">
 <label>63.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Heerding</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Rhodes</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Leber</surname>
    <given-names>J.D.</given-names>
   </name>
   <name>
    <surname>Clark</surname>
    <given-names>T.J.</given-names>
   </name>
   <name>
    <surname>Keenan</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Lafrance</surname>
    <given-names>L.V.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Safonov</surname>
    <given-names>I.G.</given-names>
   </name>
   <name>
    <surname>Takata</surname>
    <given-names>D.T.</given-names>
   </name>
   <name>
    <surname>Venslavsky</surname>
    <given-names>J.W.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase</article-title>
  <source>J. Med. Chem.</source>
  <year>2008</year>
  <volume>51</volume>
  <fpage>5663</fpage>
  <lpage>5679</lpage>
  <pub-id pub-id-type="doi">10.1021/jm8004527</pub-id>
  <?supplied-pmid 18800763?>
  <pub-id pub-id-type="pmid">18800763</pub-id>
 </element-citation>
</ref>
